DK0774251T3 - 3R-3'R stereoisomer af zeaxanthin til behandling af degeneration af macula hos mennesker - Google Patents

3R-3'R stereoisomer af zeaxanthin til behandling af degeneration af macula hos mennesker

Info

Publication number
DK0774251T3
DK0774251T3 DK96307928T DK96307928T DK0774251T3 DK 0774251 T3 DK0774251 T3 DK 0774251T3 DK 96307928 T DK96307928 T DK 96307928T DK 96307928 T DK96307928 T DK 96307928T DK 0774251 T3 DK0774251 T3 DK 0774251T3
Authority
DK
Denmark
Prior art keywords
zeaxanthin
macular degeneration
humans
cells
stereoisomer
Prior art date
Application number
DK96307928T
Other languages
English (en)
Inventor
Kevin M Garnett
Dennis L Gierhart
Luis H Guerra-Santos
Original Assignee
Zeavision L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/550,665 external-priority patent/US5747544A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Application filed by Zeavision L L C filed Critical Zeavision L L C
Application granted granted Critical
Publication of DK0774251T3 publication Critical patent/DK0774251T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
DK96307928T 1995-10-31 1996-10-31 3R-3'R stereoisomer af zeaxanthin til behandling af degeneration af macula hos mennesker DK0774251T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/550,665 US5747544A (en) 1995-10-31 1995-10-31 Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion

Publications (1)

Publication Number Publication Date
DK0774251T3 true DK0774251T3 (da) 2004-11-22

Family

ID=27415594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96307928T DK0774251T3 (da) 1995-10-31 1996-10-31 3R-3'R stereoisomer af zeaxanthin til behandling af degeneration af macula hos mennesker

Country Status (7)

Country Link
EP (1) EP0774251B1 (da)
AT (1) ATE270882T1 (da)
CA (1) CA2188983C (da)
DE (1) DE69632898T2 (da)
DK (1) DK0774251T3 (da)
ES (1) ES2225863T3 (da)
TW (1) TW586930B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010351C2 (nl) * 1998-10-19 2001-01-08 Werklust & Beheer B V Esters van caroteno´den voor gebruik in de preventie en behandeling van oogaandoeningen.
US20030228392A1 (en) 2002-06-06 2003-12-11 Wyeth Infant formula compositions containing lutein and zeaxanthin
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5778676B2 (ja) 2009-09-02 2015-09-16 オムニアクティブ ヘルス テクノロジーズ リミテッド 黄斑色素を含むキサントフィル組成物およびその調製方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891504A (en) 1970-07-31 1975-06-24 Hoffmann La Roche Process for the manufacture of zeaxanthin
BE790289A (fr) 1971-10-27 1973-02-15 Nestle Sa Procede de fabrication de zeaxanthine
CH572981A5 (da) 1973-07-26 1976-02-27 Nestle Sa
US4153615A (en) 1978-03-27 1979-05-08 Hoffmann-La Roche Inc. Method of producing coloring agents
DE3119383A1 (de) 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4675140A (en) 1984-05-18 1987-06-23 Washington University Technology Associates Method for coating particles or liquid droplets
US4851339A (en) 1986-04-01 1989-07-25 Hills Christopher B Extraction of anti-mutagenic pigments from algae and vegetables
DK171297B1 (da) 1987-03-27 1996-08-26 Hoffmann La Roche Fremgangsmåde til fremstilling af cyclohexenderivater som mellemprodukter til fremstilling af zeaxanthin samt cyclohexenderivater
US5227507A (en) 1987-03-27 1993-07-13 Hoffmann-La Roche Inc. Ethynylcyclohexene compounds and processes for manufacture thereof
US5180747A (en) 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
DE69018117T2 (de) * 1989-04-21 1995-10-26 Kirin Brewery Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
US5429939A (en) 1989-04-21 1995-07-04 Kirin Beer Kabushiki Kaisha DNA sequences useful for the synthesis of carotenoids
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
ES2104608T3 (es) * 1989-08-30 1997-10-16 Applied Food Biotech Inc Procedimiento para la produccion de una composicion que contiene zeaxantina utilizando un microorganismo de la especie flavobacterium multivorum.
DE4141351A1 (de) 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DE4200728A1 (de) 1992-01-14 1993-07-15 Basf Ag Stabile, fluessige praeparate fettloeslicher substanzen
US5310764A (en) 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
US5382714A (en) 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
NZ309130A (en) * 1995-06-07 2001-06-29 Howard Foundation A pharmaceutical composition containing meso-zeaxanthin optionally with lutein

Also Published As

Publication number Publication date
DE69632898T2 (de) 2005-08-04
CA2188983A1 (en) 1997-05-01
TW586930B (en) 2004-05-11
DE69632898D1 (de) 2004-08-19
ATE270882T1 (de) 2004-07-15
EP0774251A3 (da) 1997-06-18
ES2225863T3 (es) 2005-03-16
EP0774251B1 (en) 2004-07-14
CA2188983C (en) 2001-02-27
EP0774251A2 (en) 1997-05-21

Similar Documents

Publication Publication Date Title
AU6586896A (en) Fatty acid treatment
US20050267212A1 (en) Omega-3 fatty acids in the treatment of depression
WO2004069190A3 (en) Combination therapy for treating protein deficiency disorders
CA2228049C (en) Two-phase preparation
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
FI972744A0 (fi) Aminohappokokoonpanoja ja niiden käyttö kliinisessä ravinnossa
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
DK0774251T3 (da) 3R-3'R stereoisomer af zeaxanthin til behandling af degeneration af macula hos mennesker
ES2239470T3 (es) Utilizacion de materias insaponificables de aceites vegetales para la preparacion de un medicamento.
Gordon Elderly depressives: treatment and follow-up
DE3750426D1 (de) Mittel zur Verbesserung spezifischer Eigenschaften des Blutes.
ATE283060T1 (de) Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
AU5107296A (en) Aminotetralin derivative for the therapy of cardiovascular diseases
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
AR004245A1 (es) Tableta o capsula que contiene el estereoisómero 3r-3'r de zeaxantina y usos de dicho estereoisómero
EP0402208A1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
KR100749581B1 (ko) 광합성 미생물을 함유한 호흡기 질환 치료제
MX2022013214A (es) Metodos para aumentar el flujo sanguineo microvascular.
UA10235A (uk) Спосіб корекції дезадаптаційних розладів організму
Simon Weight-loss and sodium-reduction programmes reduced BP and the risk for hypertension in overweight adults with high-normal BP
Shah et al. DOUBLE BUND CONTROLLED STUDY OF PROTHIADEN IN CASES OF DEPRESSION
MD2068G2 (ro) Metodă de tratament al infecţiei cu Herpes simplex
De Wilde et al. The antidepressive effect of zimelidine and doxepin in endogenous depression: A double blind study.
MD2164F1 (en) Method of treatment of ocular contusions